BNKL (Bionik Laboratories) Cyclically Adjusted Book per Share: $24.05 (As of Mar. 2023)


BNKL Bionik Laboratories Corp BNKL
12 GF Score
Price $0.00
View Full Analysis

What is Bionik Laboratories Cyclically Adjusted Book per Share?

Bionik Laboratories BNKL -99.00% 12 Cyclically Adjusted Book per Share is $24.05 as of Mar. 2023. GuruFocus rates BNKL with a GF Score™ of 12/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Bionik Laboratories's adjusted book value per share for the three months ended in Mar. 2023 was $-0.239. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $24.05 for the trailing ten years ended in Mar. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-04), Bionik Laboratories's current stock price is $0.0001. Bionik Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2023 was $24.05. Bionik Laboratories's Cyclically Adjusted PB Ratio of today is 0.00.


Bionik Laboratories  (OTCPK:BNKL) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bionik Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.0001/24.05
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Bionik Laboratories Cyclically Adjusted Book per Share Related Terms


Bionik Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Bionik Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionik Laboratories Cyclically Adjusted Book per Share Chart

Bionik Laboratories Annual Data
Trend Dec14 Dec15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 22.20 23.49 24.05

Bionik Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.49 24.22 24.26 24.26 24.05

BNKL vs ARPC, GRST, IONM: Cyclically Adjusted Book per Share Comparison

For the Medical Care Facilities subindustry, Bionik Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bionik Laboratories Cyclically Adjusted PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bionik Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bionik Laboratories's Cyclically Adjusted PB Ratio falls into.


BNKL
12GF Score
Bionik Laboratories Corp BNKL
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bionik Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bionik Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2023 was:

Adj_Book= Book Value per Share /CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.239/301.8360*301.8360
=-0.239

Current CPI (Mar. 2023) = 301.8360.

Bionik Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201306 -0.008 233.504 -0.010
201309 -0.011 234.149 -0.014
201312 -0.016 233.049 -0.021
201403 -0.017 236.293 -0.022
201406 -0.022 238.343 -0.028
201409 -0.025 238.031 -0.032
201412 -0.568 234.812 -0.730
201503 55.509 236.119 70.958
201506 62.544 238.638 79.107
201509 54.893 237.945 69.632
201512 6.520 236.525 8.320
201603 1.748 238.132 2.216
201606 102.410 241.018 128.252
201609 80.770 241.428 100.980
201612 78.686 241.432 98.372
201703 74.083 243.801 91.718
201706 62.749 244.955 77.320
201709 58.142 246.819 71.102
201712 50.217 246.524 61.484
201803 14.947 249.554 18.078
201806 14.484 251.989 17.349
201809 11.509 252.439 13.761
201812 10.567 251.233 12.695
201903 7.484 254.202 8.886
201906 6.908 256.143 8.140
201909 6.432 256.759 7.561
201912 5.906 256.974 6.937
202003 2.659 258.115 3.109
202006 2.339 257.797 2.739
202009 2.057 260.280 2.385
202012 0.289 260.474 0.335
202103 0.587 264.877 0.669
202106 0.522 271.696 0.580
202109 0.404 274.310 0.445
202112 -0.767 278.802 -0.830
202203 0.433 287.504 0.455
202206 0.236 296.311 0.240
202209 0.077 296.808 0.078
202212 -0.077 296.797 -0.078
202303 -0.239 301.836 -0.239

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $24.05 mean?
Bionik Laboratories (BNKL) has a Cyclically Adjusted Book per Share of $24.05 as of Mar. 2023. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bionik Laboratories and its competitors.
Is Bionik Laboratories' Cyclically Adjusted Book per Share too high?
Bionik Laboratories' current Cyclically Adjusted Book per Share is $24.05. Overall, Bionik Laboratories has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bionik Laboratories' Cyclically Adjusted Book per Share compare to ARPC and GRST?
Bionik Laboratories' Cyclically Adjusted Book per Share of $24.05 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Book per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bionik Laboratories and its competitors. Bionik Laboratories's current Cyclically Adjusted Book per Share is $24.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionik Laboratories stock overvalued right now?
Bionik Laboratories (BNKL) has a current Cyclically Adjusted Book per Share of $24.05. The current Cyclically Adjusted Book per Share is $24.05. Bionik Laboratories' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Bionik Laboratories (BNKL), the current Cyclically Adjusted Book per Share is $24.05 as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionik Laboratories Business Description

Address 80 Coolidge Hill Road, Watertown, MA, USA, 02472
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
12GF Score

Get the complete analysis for BNKL

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price